MEG 21 with Supplamine® began as a tangent while researching new treatments for diabetes-related complications. While the research focused on treating and preventing kidney disease and blindness in diabetic patients, Dr. Annette M. Tobia, Ph.D., realized that, when topically applied, many of these same compounds used to treat diabetics could also be used to treat and prevent visible signs of aging in the skin. Dr. Tobia conducted seven independent trials before commercializing MEG 21 with Supplamine®.
OUR ANTI-GLYCATION SOLUTIONS
Our innovative products revolve around the glycation theory, which suggests that glucose binds to proteins and lipids in the skin, causing oxidative stress and premature aging. MEG 21 with Supplamine® is designed to combat these effects, offering solutions that plump and firm fine lines and wrinkles, even skin tone, reduce redness, brighten dark spots, and improve texture.
We envision a world where everyone has access to scientifically advanced skincare that not only addresses visible signs of aging but also improves overall skin health. Our ongoing research and development aim to continuously innovate and provide the most effective skincare products available.
Our team is led by Dr. Annette M. Tobia, Ph.D., a pioneer in the field of anti-glycation skincare. With decades of experience and a passion for scientific discovery, Dr. Tobia drives our research and development efforts, ensuring that MEG 21 remains at the forefront of skincare innovation.
At MEG 21, we believe in the power of science to transform skincare. Join us on our journey to fight glycation and oxidative stress, and achieve healthier, younger-looking skin. Discover the difference with MEG 21 with Supplamine® today.